未登录

K

Kristopher Clark

state university of new york at buffalo jacobs school of medicine and biomedical sciences

H指数:25

被引数:3,986

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Supplemental Oxygen Therapy in Advanced Lung Disease—New Evidence Raises New Questions

晚期肺病中的补充氧疗——新证据引发新问题

IF6.3

2026-08-010

OAAI

The PFOX trial: exertional hypoxaemia in fibrotic ILD

PFOX试验：纤维化ILD的运动性低氧血症

The Lancet Respiratory Medicine

IF32.8

2026-02-260

PRE

Modulation of antigen presentation by first-in-class ERAP1 and ERAP2 inhibitors for the treatment of cancer and autoimmunity

JOURNAL OF IMMUNOLOGY

IF3.4

2024-05-010

PRE

Supplemental Oxygen Therapy in Interstitial Lung Disease A Narrative Review

间质性肺疾病的补充氧疗

ANNALS OF THE AMERICAN THORACIC SOCIETY

IF5.4

2023-11-012

PRE

Salt-inducible kinase 2 regulates fibrosis during bleomycin- induced lung injury

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2022-12-012

OAAI

FIRST-IN-CLASS INHIBITORS OF ERAP1 ALTER THE IMMUNOPEPTIDOME OF CANCER, DRIVING A DIFFERENTIATED T CELL RESPONSE LEADING TO TUMOR GROWTH INHIBITION

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2021-11-101

OA

Implementation of a Phenobarbital-based Pathway for Severe Alcohol Withdrawal A Mixed-Method Study

ANNALS OF THE AMERICAN THORACIC SOCIETY

IF5.4

2021-10-019

PRE

Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPD

支气管基因表达特征与患有COPD和具有COPD风险的个体的随后FEV1下降率相关

IF7.7

2021-05-1012

OA

IMMUNOPEPTIDOME CHANGES MEDIATED BY A NOVEL ERAP1 INHIBITOR LEADS TO TUMOR GROWTH INHIBITION

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2020-11-090

OAAI

Potent oral ERAP1 inhibitors modify the immunopeptidome in vivo and are novel immunotherapy agents

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Feasibility, Acceptability, and Adoption of an Inpatient Tobacco Treatment Service at a Safety-Net Hospital: A Mixed-Methods Study

ANNALS OF THE AMERICAN THORACIC SOCIETY

IF5.4

2020-01-0113

PREAI

CT7001: An orally bioavailable CDK7 inhibitor is a potential therapy for breast, small-cell lung and haematological cancers

CANCER RESEARCH

IF16.6

2018-07-013

PRE

Inhibition of SIK2 and SIK3 during differentiation enhances the anti-inflammatory phenotype of macrophages

BIOCHEMICAL JOURNAL

IF4.3

2017-02-0370

OAAI

Correlation Between Worrisome Features and Pathology of Pancreatic Cyst in a Single Center

GASTROENTEROLOGY

IF25.1

2016-04-010

PREAI

The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases

BIOCHEMICAL JOURNAL

IF4.3

2015-01-0677

OAAI

An unexpected twist to the activation of IKKβ: TAK1 primes IKKβ for activation by autophosphorylation

BIOCHEMICAL JOURNAL

IF4.3

2014-07-10100

OAAI

Protein kinase networks that limit TLR signalling

限制TLR信号传导的蛋白激酶网络

BIOCHEMICAL SOCIETY TRANSACTIONS

IF4.3

2014-01-2318

PREAI

Molecular control of the NEMO family of ubiquitin-binding proteins

泛素结合蛋白NEMO家族的分子控制

NATURE REVIEWS MOLECULAR CELL BIOLOGY

IF90.2

2013-08-29112

PREAI

PGE2 Induces Macrophage IL-10 Production and a Regulatory-like Phenotype via a Protein Kinase A-SIK-CRTC3 Pathway

JOURNAL OF IMMUNOLOGY

IF3.4

2013-01-15212

OAAI

Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2012-10-02223

OAAI